Complexo Hospitalario de Pontevedra Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01314859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Complexo Hospitalario de Pontevedra, Pontevedra, Spain

Active Ingredients

Drugs in Phase 3 Trials (2)

Atosiban (tractocile) (1 trial)

nifedipine (procardia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Obstetric Labor, Premature (Phase 3)

Premature Birth (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2